You need to be logged in to view this video

Why We Still Need Covid-19 Oral Vaccines and Treatments

Released on Thursday, March 4, 2021BIOTECH
John McCamant, editor of The Medical Technology Stock Letter, is known for helping investors pick biotech winners. Join this session to discover a unique investment opportunity in a repurposed Phase II pill, poised to treat Covid-19 by reducing viral load.

John McCamant
Medical Technology Stock Letter, Editor

Trending Now

Filter By Category
Filter By Keywords
Live Now

Money, Metals, & Mining Virtual Expo

April 20 - 22, 2021